PURPOSE: To evaluate whether variability in milrinone blood levels (MBL) occurs during administration to critically ill children after surgical repair of congenital heart disease, and the clinical relevance of this variability. METHODS: Prospective cohort study conducted in the pediatric intensive care unit of a tertiary care teaching and referral hospital. MBL were measured at three time periods after starting milrinone infusion (9-12, 18-24, 40-48 h) and at the end of the infusion. MBL were categorized as within (100-300 ng/ml) or outside the therapeutic range. Low cardiac output syndrome was defined by elevation of either lactate (>2 mmol/l) or arteriovenous oxygen difference (>30%). Five other clinical outcomes were evaluated. Regression analyses evaluated the relationships between MBL and outcomes. RESULTS: Sixty-three patients were included with a total of 220 MBL. Quantification of MBL was by high-performance liquid chromatography. Overall, 114 (52%) MBL were outside the therapeutic range: 78 (36%) subtherapeutic, and 36 (16%) supratherapeutic. Repeated-measures analysis found a significant association between supratherapeutic MBL and low cardiac output syndrome (p = 0.02), and supratherapeutic MBL were associated with arterial-central venous oxygen saturation difference >30% at time 3 (p = 0.007). CONCLUSIONS: In this cohort, nontherapeutic MBL were common. Further investigation of milrinone dosing recommendations may improve the postoperative outcomes of children.
PURPOSE: To evaluate whether variability in milrinone blood levels (MBL) occurs during administration to critically ill children after surgical repair of congenital heart disease, and the clinical relevance of this variability. METHODS: Prospective cohort study conducted in the pediatric intensive care unit of a tertiary care teaching and referral hospital. MBL were measured at three time periods after starting milrinone infusion (9-12, 18-24, 40-48 h) and at the end of the infusion. MBL were categorized as within (100-300 ng/ml) or outside the therapeutic range. Low cardiac output syndrome was defined by elevation of either lactate (>2 mmol/l) or arteriovenousoxygen difference (>30%). Five other clinical outcomes were evaluated. Regression analyses evaluated the relationships between MBL and outcomes. RESULTS: Sixty-three patients were included with a total of 220 MBL. Quantification of MBL was by high-performance liquid chromatography. Overall, 114 (52%) MBL were outside the therapeutic range: 78 (36%) subtherapeutic, and 36 (16%) supratherapeutic. Repeated-measures analysis found a significant association between supratherapeutic MBL and low cardiac output syndrome (p = 0.02), and supratherapeutic MBL were associated with arterial-central venous oxygen saturation difference >30% at time 3 (p = 0.007). CONCLUSIONS: In this cohort, nontherapeutic MBL were common. Further investigation of milrinone dosing recommendations may improve the postoperative outcomes of children.
Authors: M Hatherill; T Sajjanhar; S M Tibby; M P Champion; D Anderson; M J Marsh; I A Murdoch Journal: Arch Dis Child Date: 1997-09 Impact factor: 3.791
Authors: Karen Choong; Desmond Bohn; Douglas D Fraser; Isabelle Gaboury; James S Hutchison; Ari R Joffe; Catherine Litalien; Kusum Menon; Patrick McNamara; Roxanne E Ward Journal: Am J Respir Crit Care Med Date: 2009-07-16 Impact factor: 21.405
Authors: James M Bailey; Timothy M Hoffman; David L Wessel; David P Nelson; Andrew M Atz; Anthony C Chang; Thomas J Kulik; Thomas L Spray; Akbar Akbary; Richard P Miller; Gil Wernovsky Journal: J Pharmacokinet Pharmacodyn Date: 2004-02 Impact factor: 2.745
Authors: Jean-Francois Timsit; Giuseppe Citerio; Jan Bakker; Matteo Bassetti; Dominique Benoit; Maurizio Cecconi; J Randall Curtis; Glenn Hernandez; Margaret Herridge; Samir Jaber; Michael Joannidis; Laurent Papazian; Mark Peters; Pierre Singer; Martin Smith; Marcio Soares; Antoni Torres; Antoine Vieillard-Baron; Elie Azoulay Journal: Intensive Care Med Date: 2014-02-12 Impact factor: 17.440
Authors: Sarah Jane Commander; Daniel Gonzalez; Karan R Kumar; Tracy Spears; Michael Cohen-Wolkowiez; Kanecia O Zimmerman; Stephen J Balevic; Christoph P Hornik Journal: Cardiol Young Date: 2021-08-05 Impact factor: 1.023